Alireza Ghoreifi - Publications

Oncological outcomes of radical nephroureterectomy with or without lymphadenectomy and neoadjuvant therapy in cN+ UTUC: Insights from the ROBUUST registry.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: May 27, 2026

Letter: Preoperative Circulating Tumor DNA Predicts Upstaging and Recurrence in High-Risk Nonmuscle-Invasive Bladder Cancer Undergoing Radical Cystectomy.

Journal: The Journal of urology

Published: May 01, 2026

Re: Aboubacar Kaba, Pratik Kanabur, Jeremie Calais, et al. Performance of [89 Zr]girentuximab PET/CT in Predicting the Presence of Any Renal Malignancy: A Reanalysis of the ZIRCON Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.003.

Journal: European urology

Published: April 29, 2026

Real-world multicenter adherence to international guidelines in the management of upper tract urothelial carcinoma: insights from the ROBUUST 2.0 Registry.

Journal: Minerva urology and nephrology

Published: April 23, 2026

Evaluation, etiology, and management of gross hematuria following radical cystectomy and orthotopic neobladder.

Journal: Urologic oncology

Published: April 19, 2026

Impact of divergent differentiation and histological subtypes on oncologic outcomes in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma.

Journal: Urologic oncology

Published: February 17, 2026

Robotic versus open post-chemotherapy retroperitoneal lymph node dissection: a propensity score matched study across 11 academic medical centers.

Journal: World journal of urology

Published: February 10, 2026

Characterizing the Activity of Inflammasome-Related Genes and Their Association With Oncological Outcomes in Prostate Cancer.

Journal: The Prostate

Published: January 05, 2026

Editorial comment on "Comparison of 4 local anesthetic techniques for open radical cystectomy: A prospective, randomized controlled trial".

Journal: Urologic oncology

Published: January 05, 2026

Complete pathological response in patients with bladder cancer: predictors and outcomes.

Journal: Therapeutic advances in urology

Published: January 02, 2026

Elevated creatinine-to-hemoglobin ratio is a novel preoperative marker for worsened survival outcomes in upper tract urothelial carcinoma: analysis from the ROBUUST registry.

Journal: Minerva urology and nephrology

Published: December 18, 2025

Outcomes of consolidative surgery following enfortumab vedotin plus pembrolizumab for advanced urothelial cancer: A real-world experience.

Journal: Urologic oncology

Published: December 02, 2025